摘要
蝮蛇抗栓酶治疗肺心病急性加重期的总有效率为82.2％,明显优于肝素组(总有效率73.3％,P<0.002);对治疗机理及不良反应作了简要的讨论。
Ahylysantinfaretase was used to treat acute exacerbation of Cor pulmonale. Its all effect rate of 82. 2% was obviously superior to that of 73. 3% in Heparin group(P<0. 002). The mechanism of their treatment and their adversereactions were briefiy discussed also.
关键词
肺心病
蝮蛇抗栓酶
肝素
pulmonale heart disease/therapy
Ahylysantinfaretase/drug effect
Heparin/drug effect
